{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:45:52Z","timestamp":1762004752530,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005890","name":"Ministry of Health of the People's Republic of China (CN)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13318-015-0307-0","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T07:26:17Z","timestamp":1446708377000},"page":"759-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro"],"prefix":"10.1007","volume":"41","author":[{"given":"Bingqing","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dapeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"issue":"7","key":"307_CR1","first-page":"10865","volume":"8","author":"X Ma","year":"2015","unstructured":"Ma X, Chang M, Ouyang T, Xu D, Xu M, Ke J, et al. Combination of propranolol and sclerotherapy for treatment of infantile parotid hemangiomas. Int J Clin Exp Med. 2015;8(7):10865\u201374.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"307_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-2077.138324","volume":"7","author":"G Sethuraman","year":"2014","unstructured":"Sethuraman G, Yenamandra VK, Gupta V. Management of Infantile Hemangiomas: current Trends. J Cutaneous Aesthetic Surg. 2014;7(2):75\u201385.","journal-title":"J Cutaneous Aesthetic Surg"},{"issue":"4","key":"307_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.sempedsurg.2014.06.017","volume":"23","author":"MG Liang","year":"2014","unstructured":"Liang MG, Frieden IJ. Infantile and congenital hemangiomas. Semin Pediatr Surg. 2014;23(4):162\u20137.","journal-title":"Semin Pediatr Surg"},{"issue":"1","key":"307_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2459\/JCM.0b013e328341aed3","volume":"12","author":"P Cuccaro","year":"2011","unstructured":"Cuccaro P, Rapacciuolo A, Vitiello R, di Pietro E, Montaldo P, Esposito F, et al. Propranolol for severe hemangioma of infancy. Journal of cardiovascular medicine (Hagerstown, Md). 2011;12(1):5.","journal-title":"Journal of cardiovascular medicine (Hagerstown, Md)"},{"issue":"24","key":"307_CR5","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. New Engl J Med. 2008;358(24):2649\u201351.","journal-title":"New Engl J Med"},{"key":"307_CR6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.5604\/17322693.1120990","volume":"68","author":"M Oksiuta","year":"2014","unstructured":"Oksiuta M, Matuszczak E, Debek W, Dzienis-Koronkiewicz E, Hermanowicz A, Tylicka M. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature. Postepy Hig Med Dosw (Online). 2014;68:1138\u201344.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"1","key":"307_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128\u201340.","journal-title":"Pediatrics"},{"key":"307_CR8","doi-asserted-by":"crossref","first-page":"850193","DOI":"10.1155\/2013\/850193","volume":"2013","author":"A Fette","year":"2013","unstructured":"Fette A. Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy. Sci World J. 2013;2013:850193.","journal-title":"Sci World J"},{"issue":"4","key":"307_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jpc.12720","volume":"51","author":"CE Tan","year":"2015","unstructured":"Tan CE, Itinteang T, Leadbitter P, Marsh R, Tan ST. Low-dose propranolol regimen for infantile haemangioma. J Paediatr child Health. 2015;51(4):419\u201324.","journal-title":"J Paediatr child Health."},{"issue":"1","key":"307_CR10","first-page":"48","volume":"132","author":"JC Albuquerque","year":"2014","unstructured":"Albuquerque JC, Magalhaes RA, Felix JA, Bastos MV, Fontenele JB, Trompieri NM, et al. Treatment of children and adolescents with hemangioma using propranolol: preliminary results from a retrospective study. Sao Paulo medical journal. Rev Paul Med. 2014;132(1):48\u201354.","journal-title":"Rev Paul Med"},{"issue":"2","key":"307_CR11","first-page":"A4776","volume":"61","author":"IG Andersen","year":"2014","unstructured":"Andersen IG, Rechnitzer C, Charabi B. Effectiveness of propanolol for treatment of infantile haemangioma. Danish Med J. 2014;61(2):A4776.","journal-title":"Danish Med J"},{"issue":"3","key":"307_CR12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cbi.2010.12.014","volume":"189","author":"S Narimatsu","year":"2011","unstructured":"Narimatsu S, Nakata T, Shimizudani T, Nagaoka K, Nakura H, Masuda K, et al. Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19. Chem Biol Interact. 2011;189(3):146\u201352.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"307_CR13","first-page":"57","volume":"66","author":"CW Huang","year":"2003","unstructured":"Huang CW, Lai ML, Lin MS, Lee HL, Huang JD. Dose-response relationships of propranolol in Chinese subjects with different CYP2D6 genotypes. J Chin Med Assoc JCMA. 2003;66(1):57\u201362.","journal-title":"J Chin Med Assoc JCMA"},{"issue":"12","key":"307_CR14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/11318070-000000000-00000","volume":"48","author":"SF Zhou","year":"2009","unstructured":"Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761\u2013804.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"307_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","volume":"369","author":"UM Zanger","year":"2004","unstructured":"Zanger UM, Raimundo S, Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2004;369(1):23\u201337.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"3","key":"307_CR16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","volume":"116","author":"M Ingelman-Sundberg","year":"2007","unstructured":"Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther. 2007;116(3):496\u2013526.","journal-title":"Pharmacol Ther"},{"key":"307_CR17","unstructured":"http:\/\/www.cypalleles.ki.se\/cyp2d6.htm . Accessed 9 Dec 2014."},{"issue":"8","key":"307_CR18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2174\/138920008786049302","volume":"9","author":"SF Zhou","year":"2008","unstructured":"Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, et al. Clinical pharmacogenetics and potential application in personalized medicine. Curr Drug Metab. 2008;9(8):738\u201384.","journal-title":"Curr Drug Metab"},{"issue":"5","key":"307_CR19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0009-9236(99)70077-9","volume":"65","author":"T Tateishi","year":"1999","unstructured":"Tateishi T, Chida M, Ariyoshi N, Mizorogi Y, Kamataki T, Kobayashi S. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population. Clin Pharmacol Ther. 1999;65(5):570\u20135.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"307_CR20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygeno.2008.05.004","volume":"92","author":"S Qin","year":"2008","unstructured":"Qin S, Shen L, Zhang A, Xie J, Shen W, Chen L, et al. Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China. Genomics. 2008;92(3):152\u20138.","journal-title":"Genomics"},{"issue":"7","key":"307_CR21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1124\/dmd.108.022368","volume":"37","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Lee SS, Jung HJ, Kim HS, Park SJ, Yeo CW, et al. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans. Drug Metab Disp Biol Chem. 2009;37(7):1464\u201370.","journal-title":"Drug Metab Disp Biol Chem"},{"issue":"1","key":"307_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bcpt.12363","volume":"117","author":"DP Dai","year":"2015","unstructured":"Dai DP, Geng PW, Wang SH, Cai J, Hu LM, Hu GX, et al. In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population. Basic Clin Pharmacol Toxicol. 2015;117(1):39\u201343.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"307_CR23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","volume":"65","author":"M Graaf de","year":"2011","unstructured":"de Graaf M, Breur JM, Raphael MF, Vos M, Breugem CC, Pasmans SG. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol. 2011;65(2):320\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"307_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","volume":"172","author":"A Langley","year":"2015","unstructured":"Langley A, Pope E. Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas. Br J Dermatol. 2015;172(1):13\u201323.","journal-title":"Br J Dermatol"},{"issue":"5","key":"307_CR25","first-page":"440","volume":"67","author":"LM Kong","year":"2012","unstructured":"Kong LM, Qian MR, Hu HH, Xu SY, Yu LS, Jiang HD, et al. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10. Pharmazie. 2012;67(5):440\u20137.","journal-title":"Pharmazie"},{"issue":"5","key":"307_CR26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/bi027085w","volume":"42","author":"FP Guengerich","year":"2003","unstructured":"Guengerich FP, Hanna IH, Martin MV, Gillam EM. Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis. Biochemistry. 2003;42(5):1245\u201353.","journal-title":"Biochemistry"},{"issue":"1","key":"307_CR27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bcpt.12363","volume":"117","author":"DP Dai","year":"2015","unstructured":"Dai DP, Geng PW, Wang SH, Cai J, Hu LM, Nie JJ, et al. In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population. Basic Clin Pharmacol Toxicol. 2015;117(1):39\u201343.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"14","key":"307_CR28","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2217\/pgs.13.160","volume":"14","author":"JC Qian","year":"2013","unstructured":"Qian JC, Xu XM, Hu GX, Dai DP, Xu RA, Hu LM, et al. Genetic variations of human CYP2D6 in the Chinese Han population. Pharmacogenomics. 2013;14(14):1731\u201343.","journal-title":"Pharmacogenomics"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-015-0307-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-015-0307-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-015-0307-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-015-0307-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T07:32:38Z","timestamp":1653463958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-015-0307-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1007\/s13318-015-0307-0","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}